Not for distribution in the U.S. or to U.S. Newswires
VANCOUVER, British Columbia, Feb. 06, 2019 (GLOBE NEWSWIRE) — Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia and licensed producer, processor, and distributor of premium dried cannabis and cannabis oil. The Company is pleased to announce that its CEO and Founder Damian Kettlewell was interviewed by award-winning broadcaster, Steve Darling, from Proactive Investors Limited.
The interview (viewable here) covers some of the most recent news about Blissco, including:
- Facility expansion plans
- The strategic production and sale of value-added products
- New sales agreements
- An upcoming AI and machine learning enhanced eCommerce site
- A mobile app, “BlissConnect,” that is near completion
“Blissco signed significant partnerships in 2018 with the provinces of British Columbia and Saskatchewan and we have also begun laying the groundwork that will allow us to ship our products to Germany, Brazil, and other international markets,” said Damian Kettlewell. “On the commercialization front, our eCommerce site is scheduled to launch in the coming months and AI and machine learning will be embedded into it. We will also be launching a telemedicine app called BlissConnect to make it as convenient as possible for our patients to access our products.”
The company has been on a five-year journey and is now moving to fulfill both its medical and recreational strategy which will also include sustainable and compostable packaging.
“We are dedicated to being not only Canada’s wellness cannabis brand that truly cares about our customers but one that cares for our planet as well,” added Kettlewell.
About Blissco Cannabis Corp.
Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is a Canadian wellness cannabis brand based in British Columbia and a multi-licensed cultivator, processor, and distributor of premium cannabis.
Blissco owns and operates a state-of-the-art GPP facility located in Metro Vancouver, British Columbia with 18,000 square feet of extraction, cultivation and processing rooms. Blissco is supplying premium cannabis and small-batch Reserve whole flower and pre-rolls to the Canadian and global marketplace with a growing list of provincial cannabis boards and international distribution partners.
With a license to process cannabis oil acquired in August 2018, Blissco’s extraction lab is also in operation preparing a line of full spectrum oils for distribution in 2019.
Learn more at blissco.com.
On Behalf of the Board of Directors
BLISSCO CANNABIS CORP.
Damian Kettlewell, CEO, Founder & Chair
For further information please contact:
1 604 484-9119
investors@blissco.com
Cautionary Statements
This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.
The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.